# Ascending Dose Tolerability Trial and PK Assessment in Healthy Volunteers After Single & Multiple Oral Intake of DF2755A

> **NCT04803396** · PHASE1 · TERMINATED · sponsor: **Dompé Farmaceutici S.p.A** · enrollment: 32 (actual)

## Conditions studied

- no Condition

## Interventions

- **DRUG:** DF2755A
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04803396
- **Lead sponsor:** Dompé Farmaceutici S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-15
- **Primary completion:** 2019-06-29
- **Final completion:** 2019-06-29
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** The Sponsor decided to not proceed from SAD to MAD to explore the possibility of further studying PD.
- **Last updated:** 2024-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04803396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04803396, "Ascending Dose Tolerability Trial and PK Assessment in Healthy Volunteers After Single & Multiple Oral Intake of DF2755A". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04803396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*